S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial

Detalles Bibliográficos
Autores principales: Schmoll, H, Wittig, BW, Arnold, DA, Riera-Knorrenschild, JRK, Nietsche, DN, Kroening, HK, Mayer, FM, Andel, JA, Ziebermayr, RZ, Scheithauer, WS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Invited Speaker Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072008/
http://dx.doi.org/10.1186/2051-1426-2-S2-I2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072008/
http://dx.doi.org/10.1186/2051-1426-2-S2-I2

Ejemplares similares